ANXA5 and cervical cancer: After treatment with TMS-TMF-4f for 48 h, annexin V-positive cells were significantly increased in a concentration-dependent manner, suggesting that TMS-TMF-4f may induce cervical cancer cell death via apoptosis rather than non-specific necrosis (Figure 1b).